C1AKI9 AF NFT

Glutamyl-tRNA reductase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeidzoi6wrshevmulojxkgnovqz7hrmigb4sgqanlo375x3pbvds2hy/metadata.json
IPFS of structure file: 
bafybeibkklnw5fjysejxkbxgewjuiu23nrsejwekiueihqoqeodt2vtqne/AF-C1AKI9-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xB44F19a0cb161828322eEEd13F55d4C3C34938d2
First NFT owner address (bech32): 
genesis1k383ngxtzcvzsv3wamgn74w5c0p5jwxjy9e46q
Current NFT ID #166733 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
166733
Accession (UniProt):
C1AKI9
Name::
Glutamyl-tRNA reductase
Experimental Method:
Predicted structure
Sequence source:
Mycobacterium bovis (strain BCG / Tokyo 172 / ATCC 35737 / TMC 1019)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT C1AKI9 research and analysis (ICN3D with VR)

FASTA sequences

>sp|C1AKI9|HEM1_MYCBT Glutamyl-tRNA reductase OS=Mycobacterium bovis (strain BCG / Tokyo 172 / ATCC 35737 / TMC 1019) OX=561275 GN=hemA PE=3 SV=1 MSVLLFGVSHRSAPVVVLEQLSIDESDQVKIIDRVLASPLVTEAMVLSTCNRVEVYAVVDAFHGGLSVIGQVLAEHSGMSMGELTKYAYVRYSEAAVEHLFAVASGLDSAVIGEQQVLGQVRRAYAVAESNRTVGRVLHELAQRALSVGKRVHSETAIDAAGASVVSVALGMAERKLGSLAGTTAVVIGAGAMGALSAVHLTRAGVGHIQVLNRSLSRAQRLARRIRESGVPAEALALDRLANVLADADVVVSCTGAVRPVVSLADVHHALAAARRDEATRPLVICDLGMPRDVDPAVARLPCVWVVDVDSVQHEPSAHAAAADVEAARHIVAAEVASYLVGQRMAEVTPTVTALRQRAAEVVEAELLRLDNRLPGLQSVQREEVARTVRRVVDKLLHAPTVRIKQLASAPGGDSYAEALRELFELDQTAVDAVATAGELPVVPSGFDAESRRGGGDMQSSPKRSPSN